Posts by Raymond J. March
Raymond J. March is a Research Fellow at the Independent Institute and Assistant Professor of Agribusiness and Applied Economics at North Dakota State University.
The Covid-19 Ratchet Effect is Becoming Clearer, and More Concerning 


On June 24, Centers for Disease Control Director Dr. Rochelle Walensky extended the national eviction moratorium for tenants unable to pay rent through the end of July. First enacted last September, the moratorium hoped to prevent further Covid-19 spread by helping tenants avoid traveling to find new housing or becoming homeless.
Will the Biden Administration Let a Delta-Variant Covid-19 Crisis Go to Waste? 


Few countries have imposed more frequent and more stringent lockdown measures to combat Covid-19 than Australia. Their efforts have been so restrictive that the British Medical Journal likened them to a “health dictatorship.” Other’s are less critical. A Forbes article published in March suggests, even while US cases were in steep decline, “there is...
Read More »
New Alzheimer’s Drug Approval Could Change the FDA’s Approval Process for the Better


After the experimental treatment for Alzheimer’s named aducanumab failed a futility test, its producers Biogen and Eisai lost hope the Food and Drug Administration would ever approve it. Despite promising clinical results through the approval process, the producers abandoned their project in 2019.  Eight months later, Biogen developed an expanded dataset to reassess aducanumab’s impact...
Read More »
Ecstasy Nears FDA Approval to Treat Severe Post-Traumatic Stress Disorder


In a heart-wrenching story written in 2017, Rachael Kaplan details her lifelong struggles with Post Traumatic Stress Disorder (PTSD). Enduring chronic and severe abuse as a child, Rachael strongly considered ending her life and found herself “praying to die.” She worked with several therapists and numerous multiple treatment methods to improve her condition. Unfortunately,...
Read More »
AstraZeneca Vaccine Controversy Provides Another Example of Overly Cautious Government Reactions


After a sluggish and error-prone beginning to a country-wide effort to vaccinate Americans against Covid-19, it seems things are quickly improving. According to the Centers for Disease Control, as of March 18th, nearly 113 million Americans have received at least Covid-19 vaccination (two of the three available vaccines require two separate injections). The agency...
Read More »
Are We Witnessing the Beginning of the Covid-19 Ratchet Effect?


Nearly 13 months after the first confirmed Covid-19 infection in the US, President Biden held a memorial as the country surpassed 500,000 deaths attributed to the pandemic. Mourning a great tragedy, President Biden noted these casualties surpass the lives lost during WWI, WWII, and the Vietnam War combined. While alarmingly high fatalities signify a...
Read More »
The FDA Should Grant Emergency Use Authorization for Alzheimer’s Drug


In March 2019, an experimental drug designed to treat Alzheimer’s disease named aducanumab failed a futility test during the process for approval from the Food and Drug Administration. Facing seemingly little hope for success, aducanumab’s producers Biogen and Eisai strongly considered abandoning the project. However, when the drugmakers conducted further analysis on a larger...
Read More »
President Biden Faces Longstanding Challenge to Lower Insulin Prices. Will He Succeed?


President Biden seems comfortable using the executive branch’s power to push his agenda. As of February 2, 2021 (less than two weeks after taking office), he has signed 25 executive orders on issues ranging from environmental policy, racial equality, Covid-19 relief, and reinstating elements of the Affordable Care Act. While passing an unprecedented amount...
Read More »
Capping Insulin Copays Won’t Cure Insulin Price Woes


In 1996, a vial of Humalog (roughly a month’s supply) cost patients about $25 per vial. By 2017, the anti-diabetes medication cost nearly $275. Insulin prices have only increased since then. A Business Insider article estimates that from 2017 to 2019 the average diabetic spent $300 to $400 for a month’s supply of insulin....
Read More »
Early Covid-19 Vaccine Distribution Troubles Add to a Long List of Government Pandemic Failures


It’s been nearly twelve months since Covid-19 reached the United States. Since then, more than 19 million U.S. citizens have contracted the disease, resulting in just over 334,000 deaths. Well-intended but often misguided policy responses have added high unemployment, financial strife, and widespread mental health concerns to an already deeply troubling situation.
  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org